• Japanese
  • Korean
  • Chinese
Cover Image

Drug Self-Administration Markets to 2020: Drug Products, Indications, Markets and Forecasts

Greystone Research Associates is pleased to announce the publication of a new market study. ‘Drug Self-Administration to 2018: Drug Products, Indications, Markets and Forecasts’ is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the drug delivery sector. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for prescription drugs packaged and supplied for patient self-administration. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Product Strategies and the Shift in Patient Care to Self-Administration

A number of factors are converging to create both risk and opportunity for drug makers and their delivery device partners. These include new classes of drugs for previously refractory conditions, growing trend toward self-administration for chronic diseases, shifting patient demographics in industrial countries, caregiver safety legislation, and continued pressure to control healthcare costs. These factors are giving rise to a new generation of sophisticated, application-specific injection, inhalation and transdermal drug products designed to satisfy caregiver and patient preferences while addressing managed care initiatives and the formulation limitations of new classes of therapeutic drugs. Because of their ability to safely and reliably satisfy treatment protocols and compliance goals, non-oral drug delivery products will have a significant impact on the future of drug selfadministration.

Feature Summary

  • Provides detailed analysis of drug self-administration market segments, market dynamics and market demographics
  • Analyzes therapeutic demand drivers and evaluates commercial drug products in more than two dozen major self-administration therapeutic segments
  • Analyzes design factors, material selection issues, technologies and market development issues for injection devices, inhalation devices and transdermal drug products designed for self-administration
  • Charts product data, market share, and forecasts to 2018
  • Profiles self-administration drug product and device participants, their product development activities, business strategies, and corporate alliances and affiliations
  • Assesses the importance of pharma-device alliances and design partnerships on drug self-administration commercialization
  • Evaluates the impact of economic, technology, and regulatory factors

Table of Contents

Executive Summary

The Market Opportunity

  • Drug Market Dynamics
  • Evolving Drug Market Factors
  • Chronic Disease and Self-administration
  • Managed Care and Prescribing Trends
  • Drug Self-Administration Demand Factors

Drug Self-Administration Product Segments and Market Drivers

Injectable Drug Self-Administration Products

  • Prefilled Syringes (PFS)
  • Pen Injectors
  • Needle-free Injectors (NFI)

Inhaled Drug Self-Administration Products

  • The Upper Respiratory Market
  • The Systemic/Deep Lung Market
  • Inhaler Product Segments
  • Performance Factors

Transdermal Drug Products

  • Market Sector Dynamics
  • Prescription Patch Design & Technology
  • Prescription Patch Development Factors
  • Key Transdermal Therapeutic Markets
  • Transdermal Product Company Profiles

Drug Self-Administration - Therapeutic Sector Analysis & Forecasts

  • ADHD
  • Anticoagulants
  • Arthritis
  • Asthma/COPD
  • Cardiovascular
  • Contraception
  • Cystic Fibrosis
  • Diabetes
  • Hematopoietics
  • Hepatitis
  • Hormone Therapy/Replacement
  • Multiple Sclerosis
  • Neurology
  • Osteoporosis
  • Pain Management
  • Psoriasis
  • Sexual Health

Company Profiles

Note: The Table of Contents has Been Edited for Brevity. For a Completed Version, Please Request a Free Sample.

Show More
Pricing
Get Notified
Email me when related reports are published